SC 13G

Company

Dianthus Therapeutics, Inc. /DE/

Filed

May 15, 2023

Accession Number

0001104659-23-060873

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →